Allergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
L. Perrigo's Allergy Relief 180 mg tablets are being recalled due to failed impurity and degradation specifications. The recall affects 32,904 cartons distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a drug recall for failed impurity and degradation specifications with no reported illnesses or injuries. Per the rubric, a risk-of-harm product where injury has not yet been reported qualifies for a score of 3 (High).
Plain-English summary
L. Perrigo Company is recalling Allergy Relief Fexofenadine Hydrochloride Tablets (180 mg) due to failed impurity and degradation specifications. The affected product was distributed nationwide by Publix Super Markets, Inc.
The recall affects 32,904 cartons in two package sizes: 30-count and 45-count cartons. Affected lot numbers include 2CR0652, 2DR0464, and 2DR0465 (expiration 12/23); 2ER0285 (expiration 01/24); 2DR0466 (expiration 12/23); 2ER0412 (expiration 01/24); and 2GR0330 (expiration 04/24).
Consumers who have purchased this product should stop using it and return the cartons to their point of purchase. For questions about your allergy medication, speak with a healthcare provider or pharmacist.
The recalled product
- Product
- ALLERGY RELIEF (FEXOFENADINE HYDROCHLORIDE)
- Brand
- ALLERGY RELIEF
- Manufacturer
- L. Perrigo Company
- Category
- Drug — OTC Antihistamine
- Hazard
- impurity
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: a) 2CR0652
- 2DR0464
- 2DR0465
- Exp. Date 12/23
- 2ER0285
- Exp. Date 01/24. b) 2DR0466
- 2ER0412
- Exp. Date 01/24
- 2GR0330
- Exp. Date 04/24
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ALLERGY RELIEF
- ModerateOTC Allergy Relief Medication Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27